Radio and PodcastRadio and PodcastLive Radio & Podcasts
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma artwork
Science & Medicine

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association

Oct 24, 202420:41Science & Medicine

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–P...

About This Episode

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma is an episode from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medi...

Podcast

This episode belongs to JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Oct 24, 2024, 20:41 long, audio available.

Related Episodes

Continue listening to more episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.